补充激活与右心室功能障碍和肺栓塞的严重程度有关:与前血栓状况的联系
Paweł Rostoff1, Michał Ząbczyk2,3, Joanna Natorska2,3
1Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, St. John Paul II Hospital, Krakow, Poland.
Journal of thoracic disease
|June 17, 2024
概括
在急性肺栓塞 (PE) 中补充剂的激活与较差的结果有关. 增加的补体标记与更密集的血栓和增加的风险相关,这表明它在血栓栓塞瘤中发挥了作用.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 肺部医学 肺部医学
背景情况:
- 补充激活在急性肺栓塞 (PE) 中的作用仍然在很大程度上是未知的.
- 调查补充剂与PE严重程度,前血栓状况,炎症和NETs形成的关联至关重要.
研究的目的:
- 为了确定补充激活和急性PE严重程度之间的关系.
- 探索补充剂激活与前列血栓标记物,全身炎症和PE患者的NETs形成的关联.
主要方法:
- 在服用抗凝剂之前研究了109名非癌症PE患者.
- 测量了血补充成分 (C3a,sC5b-9),血栓生成,纤维解蛋白,第八因子 (FVIII) 活性和凝块特性 (透性,溶解时间).
- 通过素化基因素H3评估炎症标志物和中性粒细胞外细胞陷 (NETs).
主要成果:
- 较低的C3a水平与较低的PE严重性指数 (sPESI) 和较少的右心室 (RV) 功能障碍相关.
- 升高的C3a与更密集,较难溶解的血块 (较低的Ks,更高的CLT) 和更高的FVIII活性有关.
- sC5b-9仅与更高的FVIII活性有关.
结论:
- 在急性PE中增强的补充激活表明短期预后较差.
- 补充剂激活与前血栓性纤维素凝块特性和高FVIII相关.
- 这些发现支持补充蛋白在急性血栓栓塞的参与.
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Pulmonary Hypertension: Classification and Pathogenesis
168
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
168
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Acute Respiratory Failure-II
206
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
206


